Compare
Abbott Laboratories vs Integra Lifesciences (ABT vs IART)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Integra Lifesciences (IART) +17.7%; so far this year the figures are -12.3% and +8.1%.
Abbott Laboratories is the larger company by market value, about 183.1 times the size of Integra Lifesciences.
On trailing earnings, ABT trades at 40.9 times and IART at 78.9 times.
Revenue grew +10.0% at ABT and +0.8% at IART over the last year.
ABT yields 2.29%. IART pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | IART | |
|---|---|---|
| Price | $109.93 | $13.42 |
| 1-day | -3.23% | -4.96% |
| YTD | -12.26% | +8.05% |
| 1 year | -11.73% | +17.72% |
| 3 years | +15.70% | -63.58% |
| Market cap | $190.4B | $1.0B |
| P/E | 40.9 | 78.9 |
| P/S | 3.95 | 0.63 |
| P/B | 3.73 | 0.98 |
| Revenue growth | +10.00% | +0.80% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 52.4 |
| Net margin % | 9.7 | 0.8 |
| ROE % | 9.2 | 1.2 |
| Debt / equity | 0.61 | 0.65 |
| FCF yield % | 3.5 | 8.2 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 1.50 |
| RSI (14) | 58.5 | 48.3 |
| Technical rating |